Dr. Chris Hudson
BSc (Hons), PhD, PgCUT, MCOptom, FAAO
Chris Hudson joined the Faculty of the School of Optometry, University of Waterloo, as an Associate Professor in March 2000 and was promoted to Professor in March 2007. He currently teaches physiology of the eye, diseases of the eye and clinical optometry. He also currently holds appointments as Professor, Department of Ophthalmology and Vision Science, University of Toronto; and Scientist, Toronto Western Research Institute. He was appointed to Graduate Faculty, Institute of Medical Science and School of Graduate Studies, University of Toronto in 2001 and the Cardiovascular Sciences Collaborative Program, University of Toronto in 2002. In addition, he was appointed as Director of Retinal Research at The University Health Network in 2004.
Within 12 months of arriving in Canada, he was awarded a CIHR New Investigator Award and Operating Grant, a Premier’s Research Excellence Award and Canada Foundation for Innovation infrastructure funding. He is currently Principal Investigator of two CIHR-operating grant projects and also holds industry funding. Current research is examining the relationship between systemic markers of endothelial function and the functional assessment of retinal vascular reactivity in healthy subjects and patients with diabetes and glaucoma. Chris Hudson runs a productive research lab with interests in the areas of the non-invasive psychophysical, imaging and blood flow assessment of the eye in healthy ageing and ocular and systemic disease. To date, he has (co-) authored over 65 peer reviewed papers, 3 book chapters and holds 1 patent and he has supervised 10 Masters students, 6 Doctoral students and 6 Post-Doctoral Fellows. In 2009, he was appointed General Secretary of the Association for Ocular Circulation.
Read about some of the researchers who currently received grants from the Glaucoma Research Society
Stay up to date with all that is going on with the Glaucoma Research Society of Canada. Get our newsletter and the latest updates straight to your inbox.